Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-09-20

Clinical Trial Update: A Study of the Effect of Nebivolol to Evaluate Its Vasodilatory Effects in Hypertensive Patients [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating Nebivolol's vasodilatory effects in hypertensive patients; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nebivolol (Nebivolol)

Snippet

Sponsor: Forest Laboratories | Conditions: Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2010-09-20